News and Views

TSRI alumnus and new faculty member Keary Engle is looking for faster, more environmentally sustainable ways to create important drug compounds.

The research, which the Loring lab will conduct with colleagues at two German institutes, will focus on stem cell quality.

Vigilance is a first defense.

New Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
Team Identifies Potential Target for Individualized Treatment of Autism Spectrum Disorder
Researchers Identify Promising Drug Candidate to Treat Chronic Itch that Avoids Side Effects
Scientists Identify a Key Morphine Regulator that May Reduce Risk of Pain-Killer Abuse and Addiction
Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President
TSRI and UC San Diego Launch New Consortium to Create ‘Virtual Cell’
Institute Receives $5.65 Million Gift from San Diego Philanthropist Helen Dorris
Institute Receives $12.5 Million Challenge Gift
Study by TSRI and Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Scientists Show How Aging Cripples the Immune System, Suggesting Benefits of Antioxidants
Team Finds a Better Way to Engineer Therapeutic Proteins into Antibodies
International Team Discovers the Ancient Origins of Deadly Lassa Virus
Team Makes Strides in Therapy Preventing Addiction Relapse by Erasing Drug-Associated Memories
Technology Meets Teamwork: Andrew Ward Unlocks Viruses’ Secrets
Team Finds New Antibody Weapons against Marburg Virus